
|Articles|December 10, 2021
Daily Medication Pearl: Glipizide (Glucotrol)
Author(s)Saro Arakelians, PharmD
Glipizide stimulates beta cells to produce more insulin in the body.
Advertisement
Medication Pearl of the Day: Glipizide (Glucotrol)
Indication: Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class.
Insight:
- Dosing: The recommended starting dose is 5 mg, given before breakfast. Geriatric patients or those with liver disease may be started on 2.5 mg.
- Dosage forms: 5 mg and 10 mg
- Adverse events: Includes gastrointestinal disturbances, erythema, low blood sugars, leukopenia, hyponatremia, dizziness, and drowsiness.
- Mechanism of action: Glipizide stimulates the beta cells of the pancreas to produce more insulin in the body.
- Manufacturer: Pfizer
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
5












































































































































































































